Necessity is the mother of invention: an ingenious method for leukocyte-targeted delivery of siRNA in stabilized nanoparticles demonstrates a role of cyclin D1 in inflammation.
Kakuta
Hiroki
H
Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 1-1-1 Tsushima-Naka, Okayama 700-8530, Japan. kakuta@pharm.oayama-u.ac.jp
D000818:Animals; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D019938:Cyclin D1 / Q000378:metabolism*; D016503:Drug Delivery Systems; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D007962:Leukocytes / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D053758:Nanoparticles / Q000737:chemistry*; D034741:RNA, Small Interfering / Q000008:administration & dosage* / Q000737:chemistry / Q000494:pharmacology
D034741:RNA, Small Interfering; D019938:Cyclin D1